Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Board/Management Information 2017

Apr 7, 2017

29871_rns_2017-04-07_2ec1322e-d519-4489-b606-55ebd89e24b2.zip

Board/Management Information

Open in viewer

Opens in your device viewer

CoverPageHeader end CoverPageTitle START

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 6, 2017

CoverPageTitle END CoverPageRegistrant START

CME Group Inc. ______ (Exact name of registrant as specified in its charter)

Delaware 001-31553 36-4459170
___ (State or other jurisdiction _______ (Commission __ (I.R.S. Employer
of incorporation) File Number) Identification No.)
20 South Wacker Drive, Chicago, Illinois 60606
_________ (Address of principal executive offices) _____ (Zip Code)

Registrant’s telephone number, including area code: 312-930-1000

Not Applicable __________ Former name or former address, if changed since last report

CoverPageRegistrant END

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

PageBreak START

Top of the Form

PageBreak END Item START

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 6, 2017, James E. Oliff, a director of CME Group Inc. (the "Company") at that time, notified the Company that he would resign from the Company's Board of Directors effective immediately. Mr. Oliff's decision to resign did not involve any disagreement with the Company, the Company's management or the Board of Directors.

Item END

PageBreak START

Top of the Form

PageBreak END SignatureHeader START

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SignatureHeader END Signature START

Kathleen M. Cronin
Name: Kathleen M. Cronin
Title: Managing Director, General Counsel & Corporate Secretary

Signature END HTMLFooter START